MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that more…
SOLVE-RD Program Will Sequence More Than 500 Human Genomes With SMRT Sequencing MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider…
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2019. On April…
Service Provider Adds Two More Sequel II Systems to Meet Growing Demand for Long-Read Sequencing Data MENLO PARK, Calif., August 6, 2019 — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading…
Identification of Pathogenic Structural Variants with SMRT Sequencing Improves Solve Rate for Rare and Mendelian Diseases MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) — While DNA sequencing tools have…
MENLO PARK, Calif., May 03, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached….
New system is ideally suited for comprehensive variant detection, large genome de novo assembly, human structural variant characterization, whole transcriptome analysis, and more MENLO PARK, Calif., April 24, 2019 (GLOBE…
In a retrospective study, Anthony Nolan Research Institute found SMRT® Sequencing identified superior HLA matches, which are critical in determining successful transplant outcomes MENLO PARK, Calif., April 02, 2019 (GLOBE…
Customers to Present Results from a Range of Market Areas Including Human Biomedical, Evolutionary Biology, and AgBio; Company to Present New Methods for Single-Cell Isoform Sequencing and Low-Input DNA Protocol…
MENLO PARK, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2018,…
Improved Reference Genome for Aedes aegypti, Carrier of Zika Virus and Other Public Health Threats, Published in Nature MENLO PARK, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of…
Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome Pacific Biosciences’ Recent Advances with its Sequel SMRT® Technology, Combined…
MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2018. Total revenue…
MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results…
Highlights include release of new chemistry and more than 25 presentations demonstrating utility of SMRT Sequencing for human genetics applications MENLO PARK, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) — Pacific…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.